Comparing two medicines with light therapy for newborn jaundice
Part of Genetic & congenital clinical trials.
This trial compares two medicines, fenofibrate and phenobarbitone, added to standard light therapy to see which works better at lowering bilirubin levels in full-term newborns with jaundice. It aims to find a faster or more effective way to treat jaundice and reduce the need for more intensive treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be between 24 hours and 14 days old.
- Your baby must have been born at full term (37 to 42 weeks of pregnancy).
- Your baby must weigh at least 5.5 pounds (2500 grams) at birth.
- Your baby's jaundice must be the common, non-serious type (called physiologic) and not caused by blood type issues or other health problems.
- Your baby's bilirubin level must be between 15 and 20 mg/dL and need light therapy.
- You or your baby's legal guardian must agree to the trial in writing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving probiotics (healthy bacteria) to newborns with jaundice helps them get better faster when they are also receiving light therapy (phototherapy). It is for babies with moderate jaundice who need treatment and do not have other serious health issues.
This trial checks whether a new device can accurately detect and track yellowing of the skin (newborn jaundice) in hospitals with limited resources. It may help clinicians monitor jaundice and decide on treatments like blue light therapy more reliably.
This study tests a new phototherapy (special light treatment) device to treat newborn jaundice. It may help by seeing whether this device can treat jaundice safely and effectively.
This trial tests if giving a zinc or bile acid medicine alongside light therapy helps break down jaundice faster in newborns. It could shorten treatment time for babies who need phototherapy in their first week of life.
This trial tests different ways to give light therapy to newborns with jaundice. It compares different approaches to see which is best, and may help parents understand the most effective treatment for their baby.
This trial compares different blood-bilirubin (jaundice) thresholds for treating very premature babies (born before 30 weeks) in the NICU. It aims to find the safest way to manage jaundice to prevent complications.
Hear when a new Jaundice, Neonatal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.